Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The ancient cell death suppressor BAX inhibitor-1.
Henke N, Lisak DA, Schneider L, Habicht J, Pergande M, Methner A. Henke N, et al. Among authors: lisak da. Cell Calcium. 2011 Sep;50(3):251-60. doi: 10.1016/j.ceca.2011.05.005. Epub 2011 Jun 12. Cell Calcium. 2011. PMID: 21663964 Review.
BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survival.
Lisak D, Schacht T, Gawlitza A, Albrecht P, Aktas O, Koop B, Gliem M, Hofstetter HH, Zanger K, Bultynck G, Parys JB, De Smedt H, Kindler T, Adams-Quack P, Hahn M, Waisman A, Reed JC, Hövelmeyer N, Methner A. Lisak D, et al. Cell Death Differ. 2016 Feb;23(2):358-68. doi: 10.1038/cdd.2015.115. Epub 2015 Oct 16. Cell Death Differ. 2016. PMID: 26470731 Free PMC article.
Bax Inhibitor-1-mediated Ca2+ leak is decreased by cytosolic acidosis.
Kiviluoto S, Luyten T, Schneider L, Lisak D, Rojas-Rivera D, Welkenhuyzen K, Missaen L, De Smedt H, Parys JB, Hetz C, Methner A, Bultynck G. Kiviluoto S, et al. Among authors: lisak d. Cell Calcium. 2013 Sep;54(3):186-92. doi: 10.1016/j.ceca.2013.06.002. Epub 2013 Jul 16. Cell Calcium. 2013. PMID: 23867001
The transmembrane Bax inhibitor motif (TMBIM) containing protein family: Tissue expression, intracellular localization and effects on the ER CA²⁺-filling state.
Lisak DA, Schacht T, Enders V, Habicht J, Kiviluoto S, Schneider J, Henke N, Bultynck G, Methner A. Lisak DA, et al. Biochim Biophys Acta. 2015 Sep;1853(9):2104-14. doi: 10.1016/j.bbamcr.2015.03.002. Epub 2015 Mar 9. Biochim Biophys Acta. 2015. PMID: 25764978 Free article.
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
Albrecht P, Bouchachia I, Goebels N, Henke N, Hofstetter HH, Issberner A, Kovacs Z, Lewerenz J, Lisak D, Maher P, Mausberg AK, Quasthoff K, Zimmermann C, Hartung HP, Methner A. Albrecht P, et al. Among authors: lisak d. J Neuroinflammation. 2012 Jul 7;9:163. doi: 10.1186/1742-2094-9-163. J Neuroinflammation. 2012. PMID: 22769044 Free PMC article.
Interaction of Bcl-2 with the autophagy-related GABAA receptor-associated protein (GABARAP): biophysical characterization and functional implications.
Ma P, Schwarten M, Schneider L, Boeske A, Henke N, Lisak D, Weber S, Mohrlüder J, Stoldt M, Strodel B, Methner A, Hoffmann S, Weiergräber OH, Willbold D. Ma P, et al. Among authors: lisak d. J Biol Chem. 2013 Dec 27;288(52):37204-15. doi: 10.1074/jbc.M113.528067. Epub 2013 Nov 15. J Biol Chem. 2013. PMID: 24240096 Free PMC article.
Long-term therapy with glatiramer acetate in multiple sclerosis: effect on T-cells.
Ragheb S, Abramczyk S, Lisak D, Lisak R. Ragheb S, et al. Among authors: lisak d, lisak r. Mult Scler. 2001 Feb;7(1):43-7. doi: 10.1177/135245850100700108. Mult Scler. 2001. PMID: 11321193
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy.
Khan OA, Zvartau-Hind M, Caon C, Din MU, Cochran M, Lisak D, Tselis AC, Kamholz JA, Garbern JY, Lisak RP. Khan OA, et al. Among authors: lisak d, lisak rp. Mult Scler. 2001 Jun;7(3):185-8. doi: 10.1177/135245850100700309. Mult Scler. 2001. PMID: 11475443 Clinical Trial.
Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).
Balabanov R, Lisak D, Beaumont T, Lisak RP, Dore-Duffy P. Balabanov R, et al. Among authors: lisak d, lisak rp. Clin Diagn Lab Immunol. 2001 Nov;8(6):1196-203. doi: 10.1128/CDLI.8.6.1196-1203.2001. Clin Diagn Lab Immunol. 2001. PMID: 11687463 Free PMC article. Clinical Trial.